PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as...
Continue Reading →
News

GSK aim for HIV cure by 2030

Following its recent approval of an injectable HIV-1 treatment from the National Institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hope...
Continue Reading →
News

New depression treatment options from NICE

The National Institute for Health and Care Excellence (NICE) has created a new menu of treatment options for those living with depression. It is the first guide...
Continue Reading →
News

NICE recommends risdiplam for spinal muscular atrophy

NICE has published draft guidance recommending risdiplam (Evrysdi) as part of a managed access agreement (MAA) for the treatment of the rare genetic disorder spinal ...
Continue Reading →
News

NICE recommends cenobamate for treatment of adult epilepsy patients in UK

NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with uncontrolled epile...
Continue Reading →
News

NICE does not recommend tucatinib for advanced breast cancer

NICE has published draft guidance for public consultation which does not recommend tucatinib, in combination with trastuzumab and capecitabine, for some types of bre...
Continue Reading →
News

NICE recommends first sickle cell disease treatment in two decades

The National Institute for Health and Care Excellence (NICE) has recommended that a new therapy for sickle cell disease is made available on the NHS for the first ti...
Continue Reading →
News

NICE recommends Novartis’ secukinumab for children with moderate to severe psoriasis

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Cosentyx® (secukinumab) as an option for treating moderate to severe plaque ps...
Continue Reading →
News

Kuvan approved for pregnant women with PKU in UK

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending BioMarin's Kuvan (sapropterin) as an option for treating ph...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026